(HYUP) Xtrackers High Beta High - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330512599 • High Yield Bond

HYUP: High, Yield, Bond, US, Corporate, Debt, Securities

The Xtrackers High Beta High Yield Bond ETF (NYSE ARCA: HYUP) is designed to provide exposure to the higher-risk, higher-reward segment of the U.S. dollar-denominated high yield corporate bond market. The fund invests at least 80% of its total assets in the component securities of its underlying index, which is engineered to capture the performance of high beta bonds within the broader high yield market. These bonds, typically issued by companies with lower credit ratings, exhibit greater sensitivity to market movements compared to their lower-beta counterparts, offering the potential for higher returns in rising markets but also exposing investors to increased volatility during downturns.

From a technical standpoint, HYUP has shown recent weakness, with its last price of 41.37 sitting below its 20-day SMA of 42.02 and 50-day SMA of 41.83, though it remains above its 200-day SMA of 40.51. This indicates short-term downward momentum but longer-term stability. The funds average trading volume over the past 20 days is 1,229 shares, reflecting limited liquidity. The ATR of 0.12 suggests relatively low volatility, though this may not hold during periods of market stress.

Fundamentally, HYUP manages a modest AUM of $10.49 million, which may limit its operational efficiency compared to larger competitors. High yield bond ETFs like HYUP are sensitive to shifts in credit spreads and interest rates, with potential headwinds from rising rates increasing the cost of borrowing for already leveraged issuers. The funds focus on higher-beta bonds amplifies these risks, making it more suitable for investors seeking enhanced income and capital appreciation in a rising market cycle.

Over the next three months, HYUP is likely to face headwinds due to its low average volume and exposure to higher-risk bonds. The funds price may struggle to regain its 20-day and 50-day SMAs unless broader market sentiment improves. However, if credit spreads tighten and investor appetite for risk increases, HYUP could outperform its peers given its focus on higher-beta securities. Investors should monitor the funds liquidity and the broader high yield market conditions closely during this period.

Additional Sources for HYUP ETF

HYUP ETF Overview

Market Cap in USD 10m
Category High Yield Bond
TER 0.20%
IPO / Inception 2018-01-11

HYUP ETF Ratings

Growth 5y 62.3%
Fundamental -
Dividend 71.9%
Rel. Strength Industry 8.8
Analysts -
Fair Price Momentum 43.26 USD
Fair Price DCF -

HYUP Dividends

Dividend Yield 12m 7.93%
Yield on Cost 5y 11.47%
Annual Growth 5y -0.43%
Payout Consistency 96.0%

HYUP Growth Ratios

Growth Correlation 3m 72.1%
Growth Correlation 12m 97.6%
Growth Correlation 5y 58.3%
CAGR 5y 7.98%
CAGR/Max DD 5y 0.44
Sharpe Ratio 12m 1.90
Alpha 4.24
Beta 0.23
Volatility 5.06%
Current Volume 1.1k
Average Volume 20d 1.3k
What is the price of HYUP stocks?
As of March 15, 2025, the stock is trading at USD 41.59 with a total of 1,108 shares traded.
Over the past week, the price has changed by -1.14%, over one month by -1.16%, over three months by +0.23% and over the past year by +9.90%.
Is Xtrackers High Beta High a good stock to buy?
Yes. Based on ValueRay Analyses, Xtrackers High Beta High (NYSE ARCA:HYUP) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.29 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HYUP as of March 2025 is 43.26. This means that HYUP is currently overvalued and has a potential downside of 4.02%.
Is HYUP a buy, sell or hold?
Xtrackers High Beta High has no consensus analysts rating.
What are the forecast for HYUP stock price target?
According to ValueRays Forecast Model, HYUP Xtrackers High Beta High will be worth about 47.1 in March 2026. The stock is currently trading at 41.59. This means that the stock has a potential upside of +13.25%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 47.1 13.2%